• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WILLIAM COOK EUROPE ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WILLIAM COOK EUROPE ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS; MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number G35355
Medical Device Problem Code Appropriate Device Problem Term/Code Not Available (3191)
Health Effect - Clinical Code No Code Available (3191)
Date of Event 12/11/2019
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Manufacturers ref# (b)(4).(b)(4).Investigation is still in progress.
 
Event or Problem Description
Description of event according to initial reporter: alpha device used for a thoracic aneurysm.Looks like a type 3 endoleak at steepest curve of the arch.Reintervention on (b)(6) 2019 to implant another alpha (zta-p-38-167-w) to seal off leak.The patient no longer has a leak.First implant was tuesday, (b)(6) 2019.The doctor scanned the patient (b)(6) 2019 and saw an endoleak.He wasn¿t sure if it was a type 1a or type 3.He lined the graft with a new alpha on (b)(6) 2019.The patient does not have a leak any more.The graft landed in zone 2, just distal to the carotid artery.Patient outcome: the patient did require additional procedures due to this occurrence: an additional implant of an alpha device was scheduled for (b)(6) 2019 to seal off endoleak.A zta-p-38-167-w was implanted on (b)(6) 2019.Doctor is happy with final result.Has the complainant reported that the product caused or contributed to the adverse effects: no.
 
Additional Manufacturer Narrative
Manufacturers ref# pr287522 summary of investigational findings: a male patient with thoracic aortic aneurism had a tevar procedure performed (b)(6) 2019, where zta-p-36-161-w (complaint device) was implanted in zone 2.The physician scanned the patient (b)(6) 2019 and found an endoleak, not sure if it was a type 1a or a type 3 endoleak.Therefore the patient underwent another tevar procedure where an additional stentgraft (zta-p-38-167-w) was implanted, lined with the existing stentgraft, and sealing the leak.The endoleak was no longer there.No adverse effects to the patient have been reported.½review of the device history record gave no indication of the device being produced outside of specifications.The ifu sent with the device states: ¿patients experiencing leaks or reduced blood flow through the graft may be required to undergo secondary endovascular interventions or surgical procedures¿ and according to the ifu, endoleak is a known adverse event.A likely cause for this event could not be established.Cook will reopen the investigation if further imaging or information is received.Cook medical will continue to monitor for similar events.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
No additional information regarding the patient and/or event has been received since the previous medwatch report was sent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT PROXIMAL COMPONENTS
Common Device Name
MIH SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
WILLIAM COOK EUROPE
sandet 6
bjaeverskov 4632
DA  4632
MDR Report Key9556580
Report Number3002808486-2020-00002
Device Sequence Number11333335
Product Code MIH
UDI-Device Identifier10827002353555
UDI-Public(01)10827002353555(17)221112(10)E3919966
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P140016
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/12/2022
Device Model NumberG35355
Device Catalogue NumberZTA-P-36-161-W
Device Lot NumberE3919966
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 12/16/2019
Supplement Date Received by Manufacturer05/22/2020
Initial Report FDA Received Date01/07/2020
Supplement Report FDA Received Date06/10/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-